Collette, Laurence

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 14.

Journal Article

Bührer, Emanuel; D'Haese, David; Daugaard, Gedske; de Wit, Ronald; Albany, Costantine; Tryakin, Alexey; Fizazi, Karim; Stahl, Olof; Gietema, Jourik A; De Giorgi, Ugo; Cafferty, Fay H; Hansen, Aaron R; Tandstad, Torgrim; Huddart, Robert A; Necchi, Andrea; Sweeney, Christopher J; Garcia-Del-Muro, Xavier; Heng, Daniel Y C; Lorch, Anja; Chovanec, Michal; ... (2024). Impact of teratoma on survival probabilities of patients with metastatic non-seminomatous germ cell cancer: Results from the IGCCCG Update Consortium. European journal of cancer, 202(114042), p. 114042. Elsevier 10.1016/j.ejca.2024.114042

Lauritsen, Jakob; Sauvé, Nicolas; Tryakin, Alexey; Jiang, Di Maria; Huddart, Robert; Heng, Daniel Y C; Terbuch, Angelika; Winquist, Eric; Chovanec, Michal; Hentrich, Marcus; Fankhauser, Christian D; Shamash, Jonathan; Del Muro, Xavier Garcia; Vaughn, David; Heidenreich, Axel; Sternberg, Cora N; Sweeney, Christopher; Necchi, Andrea; Bokemeyer, Carsten; Bandak, Mikkel; ... (2023). Outcomes of relapsed clinical stage I versus de novo metastatic testicular cancer patients: an analysis of the IGCCCG Update database. British journal of cancer, 129(11), pp. 1759-1765. Nature Publishing Group 10.1038/s41416-023-02443-3

Fankhauser, Christian D; Jandari, Abolghassem; Collette, Laurence; Tandstad, Torgrim; Jiang, Di Maria; De Giorgi, Ugo; Sweeney, Christopher; Terbuch, Angelika; Chovanec, Michal; Huddart, Robert; Bokemeyer, Carsten; Beyer, Jörg; Gillessen, Silke (2023). Prechemotherapy Not Preorchiectomy Serum Tumor Markers Accurately Identify International Germ Cell Cancer Collaborative Group Prognostic Groups in Nonseminoma. European urology open science, 56, pp. 25-28. Elsevier 10.1016/j.euros.2023.08.008

Beyer, Jörg; Collette, Laurence; Sauvé, Nicolas; Daugaard, Gedske; Feldman, Darren R; Tandstad, Torgrim; Tryakin, Alexey; Stahl, Olof; Gonzalez-Billalabeitia, Enrique; De Giorgi, Ugo; Culine, Stéphane; de Wit, Ronald; Hansen, Aaron R; Bebek, Marko; Terbuch, Angelika; Albany, Costantine; Hentrich, Marcus; Gietema, Jourik A; Negaard, Helene; Huddart, Robert A; ... (2021). Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium. Journal of clinical oncology, 39(14), pp. 1553-1562. American Society of Clinical Oncology 10.1200/JCO.20.03292

Gillessen, Silke; Sauvé, Nicolas; Collette, Laurence; Daugaard, Gedske; de Wit, Ronald; Albany, Costantine; Tryakin, Alexey; Fizazi, Karim; Stahl, Olof; Gietema, Jourik A; De Giorgi, Ugo; Cafferty, Fay H; Hansen, Aaron R; Tandstad, Torgrim; Huddart, Robert A; Necchi, Andrea; Sweeney, Christopher J; Garcia-Del-Muro, Xavier; Heng, Daniel Y C; Lorch, Anja; ... (2021). Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(14), pp. 1563-1574. 10.1200/JCO.20.03296

Weber, Damien Charles; Ares, Carmen; Villa, Salvador; Peerdeman, Saskia M; Renard, Laurette; Baumert, Brigitta G; Lucas, Anna; Veninga, Theo; Pica, Alessia; Jefferies, Sarah; Ricardi, Umberto; Miralbell, Raymond; Stelmes, Jean-Jacques; Liu, Yan; Collette, Laurence; Collette, Sandra (2018). Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: A phase-II parallel non-randomized and observation study (EORTC 22042-26042). Radiotherapy and oncology, 128(2), pp. 260-265. Elsevier 10.1016/j.radonc.2018.06.018

Sternberg, Cora N; Skoneczna, Iwona; Kerst, J Martijn; Albers, Peter; Fossa, Sophie D; Agerbaek, Mads; Dumez, Herlinde; de Santis, Maria; Théodore, Christine; Leahy, Michael G; Chester, John D; Verbaeys, Antony; Daugaard, Gedske; Wood, Lori; Witjes, J Alfred; de Wit, Ronald; Geoffrois, Lionel; Sengelov, Lisa; Thalmann, George; Charpentier, Danielle; ... (2015). Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial. The lancet oncology, 16(1), pp. 76-86. Elsevier 10.1016/S1470-2045(14)71160-X

Studer, Urs E.; Whelan, Peter; Wimpissinger, Florian; Casselman, Jacques; de Reijke, Theo M.; Knönagel, Hartmut; Loidl, Wolfgang; Isorna, Santiago; Sundaram, Subramanian K.; Collette, Laurence (2014). Differences in Time to Disease Progression Do Not Predict for Cancer-specific Survival in Patients Receiving Immediate or Deferred Androgen-deprivation Therapy for Prostate Cancer: Final Results of EORTC Randomized Trial 30891 with 12 Years of Follow-up. European urology, 66(5), pp. 829-838. Elsevier 10.1016/j.eururo.2013.07.024

Collette, Laurence; Studer, Urs E (2009). Selection bias is not a good reason for advising more than 5 years of adjuvant hormonal therapy for all patients with locally advanced prostate cancer treated with radiotherapy. Journal of clinical oncology, 27(33), e201-2; author reply e204. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2009.23.3601

Studer, Urs E; Collette, Laurence (2009). Prostate cancer: to screen or not to screen? Nature Reviews. Urology, 6(6), pp. 299-301. New York, N.Y.: Nature Publishing Group 10.1038/nrurol.2009.92

Studer, Urs E; Collette, Laurence (2008). Reply to Magdi Mounir Kirollos' Letter to the Editor re: Urs E. Studer, Laurence Collette, Peter Whelan, et al. Using PSA to Guide Timing of Androgen Deprivation in Patients with T0-4 N0-2 M0 Prostate Cancer Not Suitable for Local Curative Treatment (EORTC 30891). Eur Urol 2008;53:941-9 and re: John Anderson. Androgen Deprivation Therapy-It's All a Matter of Timing. Eur Urol 2008;53:869-71. European urology Amsterdam: Elsevier

Studer, Urs E; Collette, Laurence; Whelan, Peter; Albrecht, Walter; Casselman, Jacques; de Reijke, Theo; Knönagel, Hartmut; Loidl, Wolfgang; Isorna, Santiago; Sundaram, Subramanian K; Debois, Muriel (2008). Using PSA to guide timing of androgen deprivation in patients with T0-4 N0-2 M0 prostate cancer not suitable for local curative treatment (EORTC 30891). European urology, 53(5), pp. 941-9. Amsterdam: Elsevier 10.1016/j.eururo.2007.12.032

Studer, Urs E; Collette, Laurence (2006). Morbidity from pelvic lymphadenectomy in men undergoing radical prostatectomy. European urology, 50(5), 887-9; discussion 889. Amsterdam: Elsevier 10.1016/j.eururo.2006.08.014

Studer, Urs E; Whelan, Peter; Albrecht, Walter; Casselman, Jacques; de Reijke, Theo; Hauri, Dieter; Loidl, Wolfgang; Isorna, Santiago; Sundaram, Subramanian K; Debois, Muriel; Collette, Laurence (2006). Immediate or deferred androgen deprivation for patients with prostate cancer not suitable for local treatment with curative intent: European Organisation for Research and Treatment of Cancer (EORTC) Trial 30891. Journal of clinical oncology, 24(12), pp. 1868-76. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2005.04.7423

This list was generated on Wed Apr 24 06:34:32 2024 CEST.
Provide Feedback